What is the intrinsic value of SESN?
As of 2025-06-16, the Intrinsic Value of Sesen Bio Inc (SESN) is
0.48 USD. This SESN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.63 USD, the upside of Sesen Bio Inc is
-23.24%.
Is SESN undervalued or overvalued?
Based on its market price of 0.63 USD and our intrinsic valuation, Sesen Bio Inc (SESN) is overvalued by 23.24%.
SESN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(4.30) - (1.48) |
(2.21) |
-452.2% |
| DCF (Growth 10y) |
(1.52) - (4.01) |
(2.18) |
-446.1% |
| DCF (EBITDA 5y) |
(1.27) - (1.67) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(1.34) - (1.79) |
(1,234.50) |
-123450.0% |
| Fair Value |
0.48 - 0.48 |
0.48 |
-23.24% |
| P/E |
(1.15) - (1.96) |
(1.55) |
-347.1% |
| EV/EBITDA |
1.15 - 2.56 |
1.54 |
144.4% |
| EPV |
(1.09) - (1.51) |
(1.30) |
-306.7% |
| DDM - Stable |
(0.56) - (1.71) |
(1.14) |
-280.7% |
| DDM - Multi |
(0.55) - (1.38) |
(0.79) |
-226.3% |
SESN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
127.96 |
| Beta |
0.86 |
| Outstanding shares (mil) |
203.49 |
| Enterprise Value (mil) |
53.42 |
| Market risk premium |
5.00% |
| Cost of Equity |
12.64% |
| Cost of Debt |
5.00% |
| WACC |
8.24% |